Kerry Wentworth

Companies

• Nuvation Bio Inc.Chief Regulatory Officer May 25, 2022 to now¹
• Flexion TherapeuticsChief Regulatory Officer Dec 29, 2017 to Nov 19, 2021²
• AgenusVP, Reg Affairs & Clinical Ops Jul 24, 2006 to Feb 28, 2014³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• NBNuvation Bio Inc. NUVB53,000 shares⁴$235.6K at $4.45Jun 23, 2026
• FTFlexion Therapeutics0 shares⁵Nov 19, 2021

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 23, 2026Sold 63,000 shares at $6.02 of Nuvation Bio Inc.⁴
• Jun 23, 2026Exercised options 63,000 shares at $2.93 of Nuvation Bio Inc.⁴
• Apr 17, 2026Sold 36,750 shares at $5.01 of Nuvation Bio Inc.⁶
• Apr 17, 2026Exercised options 36,750 shares at $2.93 of Nuvation Bio Inc.⁶
• Apr 6, 2026Sold 200,000 shares at $4.52 of Nuvation Bio Inc.⁷
• Apr 6, 2026Exercised options 100,000 shares at $1.94 of Nuvation Bio Inc.⁷
• Apr 6, 2026Exercised options 100,000 shares at $1.87 of Nuvation Bio Inc.⁷
• Jun 16, 2025Bought 24,000 shares at $1.80 of Nuvation Bio Inc.⁸
• Jun 16, 2025Bought 26,000 shares at $1.79 of Nuvation Bio Inc.⁸
• Nov 19, 2021Returned to company 6,000 shares at $8.50 of Flexion Therapeutics⁵
• Nov 19, 2021Returned to company 140,843 shares at $8.50 of Flexion Therapeutics⁵